silybin has been researched along with Metabolic Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soukop, J; Večeřa, R | 1 |
| Bouderba, S; Detaille, D; Koceïr, EA; Sanchez-Martin, C; Villanueva, GR | 1 |
| Kazdová, L; Malínská, H; Matušková, Z; Oliyarnyk, O; Poruba, M; Tozzi di Angelo, I; Večeřa, R | 1 |
| D'Auria, M; de Sio, I; Di Leva, A; Federico, A; Loguercio, C; Niosi, M; Trappoliere, M; Tuccillo, C | 1 |
| Capristo, E; Forgione, A; Gabrieli, ML; Gallo, A; Gasbarrini, G; Grieco, A; Miele, L; Vero, V | 1 |
1 review(s) available for silybin and Metabolic Syndrome
| Article | Year |
|---|---|
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?].
Topics: Adult; Animals; Antioxidants; Cells, Cultured; Clinical Trials as Topic; Endothelial Cells; Fatty Liver; Female; Folic Acid; Hepatitis; Homocysteine; Humans; Insulin Resistance; Male; Metabolic Syndrome; Oxidative Stress; Rats; Risk Factors; Silybin; Silymarin; Time Factors; Vitamin B 12; Vitamin D; Vitamins | 2006 |
1 trial(s) available for silybin and Metabolic Syndrome
| Article | Year |
|---|---|
[Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
Topics: Adult; Aged; Biomarkers; Drug Combinations; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Middle Aged; Phospholipids; Pilot Projects; Silybin; Silymarin; Vitamin E | 2005 |
3 other study(ies) available for silybin and Metabolic Syndrome
| Article | Year |
|---|---|
Selected polyphenolic compounds and their use as a supportive therapy in metabolic syndrome.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antioxidants; Child; Diosmin; Hesperidin; Humans; Metabolic Syndrome; Quercetin; Silybin | 2022 |
Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Fatty Liver; Gerbillinae; Glutathione; Glutathione Peroxidase; Humans; Insulin; Lipids; Liver; Metabolic Syndrome; Obesity; Oxidative Stress; Silybin; Silymarin; Superoxide Dismutase | 2014 |
Positive effects of different drug forms of silybin in the treatment of metabolic syndrome.
Topics: Animals; Chemistry, Pharmaceutical; Cholesterol, HDL; Glucose; Hypertriglyceridemia; Insulin; Male; Metabolic Syndrome; Rats; Rats, Transgenic; Silybin; Silymarin; Treatment Outcome; Triglycerides | 2015 |